IDEXX Laboratories Inc.

United States of America Country flag United States of America
Sector: Medical Supplies
Ticker: IDXX
Factsheet Factsheet

Market multiple valuation of IDEXX Laboratories Inc. ( IDXX | USA)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is significantly higher than the median of its peer group: around 26.00. The company valuation of IDEXX Laboratories Inc. according to these metrics is way above the market valuation of its peer group.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is significantly higher than the average of its sector (Medical Supplies): 18.25. The company valuation of IDEXX Laboratories Inc. according to these metrics is way above the market valuation of its sector.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is slightly lower than its historical 5-year average: 55.2. The (current) company valuation of IDEXX Laboratories Inc. is therefore consistent with its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2022P/E NTM
IDEXX Laboratories Inc.Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies12.3719.1018.25
NASDAQ 10034.8622.8322.69
United States of America-0.7911.5011.65
More...
Beta (Ref: NASDAQ 100)
Levered betaUnlevered beta
1-Year1.181.17
2-Year1.181.17
3-Year1.141.13
More...
Stock Perf excl. Dividends (in USD)
IDXXNASDAQ 100Rel. Perf.
Year-to-Date-22.4%-9.0%-13.4%
1-Week-4.3%-4.2%-0.1%
1-Month-15.4%-5.0%-10.4%
1-Year3.2%11.7%-8.4%
3-Year154.5%118.8%35.6%
5-Year330.0%193.2%136.7%
More...
International Peers - IDEXX Laboratories Inc.
Company NameCtryMarket
Cap.
last (mUSD)
IDEXX Laboratories Inc.USA43 342
International Peers Median0.63
Abbott LaboratoriesUSA220 523
Roche Holding AGCHE350 921
Zoetis Inc.USA95 552
Thermo Fisher Scientifi...USA231 763
Neogen CorporationUSA3 858
GPRV Analysis
IDEXX Laboratories I...
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
More...
Quotes Chart

1-Year Rebased Stock Chart

  • IDEXX Laboratories Inc.
  • NASDAQ 100
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).